Rhythm Pharmaceuticals (RYTM) News Today $56.23 -3.54 (-5.92%) (As of 11/15/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) EVP Sells $4,434,890.13 in StockNovember 16 at 5:11 AM | americanbankingnews.comRhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Insider Sells $882,389.64 in StockNovember 14 at 8:04 AM | insidertrades.comRhythm announces publication of setmelanotide Phase 3 results in The LancetNovember 14 at 1:19 AM | markets.businessinsider.comRhythm Pharmaceuticals Announces Publication of Results from Phase 3 Study of Setmelanotide in Patients Between 2 and 5 Years Old in The Lancet Diabetes & EndocrinologyNovember 13, 2024 | globenewswire.comRhythm Pharmaceuticals Announces New Employment Inducement GrantsNovember 13, 2024 | globenewswire.comFY2024 Earnings Forecast for RYTM Issued By HC WainwrightNovember 12, 2024 | americanbankingnews.comRhythm Pharmaceuticals (NASDAQ:RYTM) Reaches New 1-Year High - Still a Buy?Rhythm Pharmaceuticals (NASDAQ:RYTM) Hits New 12-Month High - Here's WhyNovember 11, 2024 | marketbeat.comWhat is HC Wainwright's Estimate for RYTM FY2024 Earnings?Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM - Free Report) - Equities research analysts at HC Wainwright lowered their FY2024 earnings estimates for shares of Rhythm Pharmaceuticals in a report issued on Thursday, November 7th. HC Wainwright analyst R. Selvaraju now anticipates that the company wilNovember 11, 2024 | marketbeat.comRhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Insider Pamela J. Cramer Sells 4,688 SharesNovember 9, 2024 | insidertrades.comRhythm Pharmaceuticals (NASDAQ:RYTM) Reports Third Quarter 2024 Financial Results and Business UpdateNovember 9, 2024 | americanbankingnews.comPamela J. Cramer Sells 4,688 Shares of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) StockRhythm Pharmaceuticals, Inc. (NASDAQ:RYTM - Get Free Report) insider Pamela J. Cramer sold 4,688 shares of the firm's stock in a transaction that occurred on Thursday, November 7th. The stock was sold at an average price of $65.00, for a total transaction of $304,720.00. Following the sale, the insider now directly owns 13,500 shares of the company's stock, valued at approximately $877,500. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink.November 8, 2024 | marketbeat.comTD Cowen Boosts Rhythm Pharmaceuticals (NASDAQ:RYTM) Price Target to $65.00November 8, 2024 | americanbankingnews.comRhythm Pharmaceuticals’ Common Stock Faces Risks from Convertible Preferred Stock SupremacyNovember 7, 2024 | markets.businessinsider.comRhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Q3 2024 Earnings Call TranscriptNovember 7, 2024 | msn.comRhythm Pharmaceuticals price target raised to $80 from $53 at Wells FargoNovember 7, 2024 | markets.businessinsider.comRhythm Pharmaceuticals (NASDAQ:RYTM) Price Target Raised to $69.00HC Wainwright upped their target price on shares of Rhythm Pharmaceuticals from $64.00 to $69.00 and gave the company a "buy" rating in a research report on Thursday.November 7, 2024 | marketbeat.com8,594 Shares in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Acquired by Creative PlanningCreative Planning bought a new position in shares of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM - Free Report) during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 8,594 shares of the company's stock,November 7, 2024 | marketbeat.comRhythm Pharmaceuticals Reports Strong Q3 Revenue GrowthNovember 6, 2024 | markets.businessinsider.comNeedham & Company LLC Forecasts Strong Price Appreciation for Rhythm Pharmaceuticals (NASDAQ:RYTM) StockNeedham & Company LLC boosted their price objective on Rhythm Pharmaceuticals from $55.00 to $64.00 and gave the stock a "buy" rating in a research note on Wednesday.November 6, 2024 | marketbeat.comRhythm Pharmaceuticals Announces Participation in Upcoming Investor ConferencesNovember 6, 2024 | globenewswire.comPositive Clinical Data Reinforces Buy Rating for Rhythm Pharmaceuticals Amid Hypothalamic Obesity Treatment AdvancesNovember 6, 2024 | markets.businessinsider.comRhythm Pharmaceuticals: Strong Financial Performance and Pipeline Progress Justify Buy RatingNovember 6, 2024 | markets.businessinsider.comRhythm Pharmaceuticals, Inc. (RYTM) Q3 2024 Earnings Call TranscriptNovember 5, 2024 | seekingalpha.comRhythm Pharmaceuticals, Inc. 2024 Q3 - Results - Earnings Call PresentationNovember 5, 2024 | seekingalpha.comRhythm Pharmaceuticals (NASDAQ:RYTM) Reaches New 1-Year High - Time to Buy?Rhythm Pharmaceuticals (NASDAQ:RYTM) Hits New 1-Year High - Should You Buy?November 5, 2024 | marketbeat.comRhythm Pharmaceuticals Reports Third Quarter 2024 Financial Results and Business UpdateNovember 5, 2024 | globenewswire.comWhat's Next: Rhythm Pharmaceuticals's Earnings PreviewNovember 4, 2024 | benzinga.comOptimistic Buy Rating for Rhythm Pharmaceuticals Driven by Promising IMCIVREE Data and Market PotentialNovember 4, 2024 | markets.businessinsider.comStifel Nicolaus Keeps Their Buy Rating on Rhythm Pharmaceuticals (RYTM)November 4, 2024 | markets.businessinsider.comRhythm Pharmaceuticals (NASDAQ:RYTM) Stock Price Up 7.4% - Here's WhyRhythm Pharmaceuticals (NASDAQ:RYTM) Shares Up 7.4% - Here's WhyNovember 4, 2024 | marketbeat.comRhythm Pharmaceuticals Announces Five New Data Presentations at ObesityWeek® 2024November 4, 2024 | globenewswire.comAssenagon Asset Management S.A. Trims Stake in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM)Assenagon Asset Management S.A. lowered its holdings in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM - Free Report) by 91.3% during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 20,052 shares of the company's stock after sellinNovember 3, 2024 | marketbeat.comNisa Investment Advisors LLC Sells 308,107 Shares of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM)Nisa Investment Advisors LLC cut its holdings in shares of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM - Free Report) by 82.3% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 66,240 shares of the companNovember 2, 2024 | marketbeat.comNeedham & Company LLC Reiterates Buy Rating for Rhythm Pharmaceuticals (NASDAQ:RYTM)Needham & Company LLC reaffirmed a "buy" rating and set a $55.00 price objective on shares of Rhythm Pharmaceuticals in a research report on Wednesday.October 30, 2024 | marketbeat.comRhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Given Average Rating of "Moderate Buy" by AnalystsShares of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM - Get Free Report) have been given an average rating of "Moderate Buy" by the nine research firms that are currently covering the company, Marketbeat Ratings reports. One investment analyst has rated the stock with a hold rating and eight have isOctober 30, 2024 | marketbeat.comRhythm Pharmaceuticals (RYTM) Scheduled to Post Earnings on TuesdayRhythm Pharmaceuticals (NASDAQ:RYTM) will be releasing earnings after the market closes on Tuesday, November 5, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=638794)October 29, 2024 | marketbeat.com‘Rhythm of a Flower’ Takes Top Prize at Mumbai Film Festival, Sundance Winner ‘Girls Will Be Girls’ Gets Three HonorsOctober 25, 2024 | msn.comStrategic Collaborations and Regulatory Advancements Justify Buy Rating for Rhythm PharmaceuticalsOctober 25, 2024 | markets.businessinsider.comRhythm Pharmaceuticals' (RYTM) Buy Rating Reiterated at HC WainwrightHC Wainwright restated a "buy" rating and set a $64.00 target price on shares of Rhythm Pharmaceuticals in a report on Friday.October 25, 2024 | marketbeat.comRhythm Pharmaceuticals, Inc.: Rhythm Pharmaceuticals and Axovia Therapeutics Announce Joint Research Collaboration in Bardet-Biedl SyndromeOctober 24, 2024 | finanznachrichten.deSonam Kapoor-Anand Ahuja buy Nirav Modi’s iconic ‘Rhythm House’ for Rs…, it is located in…October 24, 2024 | msn.com5 things to know about Sonam Kapoor and Anand Ahuja's acquisition of Mumbai's iconic Rhythm HouseOctober 24, 2024 | msn.comRhythm Pharmaceuticals and Axovia Therapeutics Announce Joint Research Collaboration in Bardet-Biedl SyndromeOctober 24, 2024 | globenewswire.comSonam Kapoor And Anand Ahuja Buy Mumbai’s Iconic Rhythm House Worth Rs 478 Cr: ReportOctober 24, 2024 | msn.comSonam Kapoor, Anand Ahuja Buy Nirav Modi's Music Store Rhythm House For ₹47.8 Crore In MumbaiOctober 23, 2024 | msn.com‘Sorry 4 That Much’ Takes Feid to No. 1 on Latin Rhythm AirplayOctober 23, 2024 | yahoo.comOnce owned by Nirav Modi, Sonam Kapoor snaps up Mumbai’s famed Rhythm House for ₹47.8 croreOctober 23, 2024 | msn.comGuggenheim Initiates Coverage on Rhythm Pharmaceuticals (NASDAQ:RYTM)Guggenheim initiated coverage on Rhythm Pharmaceuticals in a research report on Monday. They issued a "buy" rating and a $70.00 price objective for the company.October 21, 2024 | marketbeat.comSamsung Galaxy Watch series in Malaysia finally gets Irregular Heart Rhythm Notification featureOctober 21, 2024 | msn.comThe official trailer for “Rhythm + Flow” season 2 goes liveOctober 19, 2024 | yahoo.com Get Rhythm Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for RYTM and its competitors with MarketBeat's FREE daily newsletter. Email Address “This Changes Everything” - Trump Hands Millions Massive IRS Gift (Ad)Now it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as we wait for Trump's agenda to kick in… >> YES! Send Me My FREE Gold Guide! RYTM Media Mentions By Week RYTM Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RYTM News Sentiment▼0.000.55▲Average Medical News Sentiment RYTM News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RYTM Articles This Week▼147▲RYTM Articles Average Week Get Rhythm Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for RYTM and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Morphic News Today Arvinas News Today Pliant Therapeutics News Today Annexon News Today Theravance Biopharma News Today Viatris News Today Summit Therapeutics News Today Genmab A/S News Today Vaxcyte News Today Dr. Reddy's Laboratories News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:RYTM) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Rhythm Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Rhythm Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free RYTM Stock Alerts